49 related articles for article (PubMed ID: 35666055)
1. Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C-Registry.
Tacke F; Klinker H; Boeker KHW; Merle U; Link R; Buggisch P; Hüppe D; Cornberg M; Sarrazin C; Wedemeyer H; Berg T; Mauss S;
Hepatol Commun; 2022 Sep; 6(9):2488-2495. PubMed ID: 35666055
[TBL] [Abstract][Full Text] [Related]
2. Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIV.
Requena MB; Grabar S; Lanoy E; Pialoux G; Billaud E; Duvivier C; Merle P; Piroth L; Tattevin P; Salmon D; Weiss L; Costagliola D; Lacombe K
AIDS; 2023 Jul; 37(8):1297-1306. PubMed ID: 37070541
[TBL] [Abstract][Full Text] [Related]
3. Chronic Hepatitis C: Acute Exacerbation and Alanine Aminotransferase Flare.
Kanda T; Matsumoto N; Ishii T; Arima S; Shibuya S; Honda M; Sasaki-Tanaka R; Masuzaki R; Kanezawa S; Nishizawa T; Gon Y; Ogawa M; Kogure H
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680223
[TBL] [Abstract][Full Text] [Related]
4. Real-world observational experience with direct-acting antivirals for hepatitis C: baseline resistance, efficacy, and need for long-term surveillance.
Loo N; Hanysak B; Mann J; Ramirez R; Kim J; Mitchell R; Van Frank T; Guerrero R; Hinojosa K; Christensen K; Pedicone LD; Alkhouri N; Wells J; Landaverde C; Rodas F; Lawitz E; Poordad F
Medicine (Baltimore); 2019 Jun; 98(26):e16254. PubMed ID: 31261592
[TBL] [Abstract][Full Text] [Related]
5. Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).
Carrieri P; Bourlière M; Di Beo V; Lusivika-Nzinga C; Ramier C; Antwerpes S; Protopopescu C; Lacombe JM; Pol S; Fontaine H; Mourad A; Carrat F; Duracinsky M; Marcellin F;
Qual Life Res; 2023 Dec; 32(12):3427-3438. PubMed ID: 37587323
[TBL] [Abstract][Full Text] [Related]
6. Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response.
Hallager S; Ladelund S; Christensen PB; Kjær M; Thorup Roege B; Grønbæk KE; Belard E; Barfod TS; Madsen LG; Gerstoft J; Tarp B; Krarup HB; Weis N
Clin Epidemiol; 2017; 9():501-516. PubMed ID: 29123424
[TBL] [Abstract][Full Text] [Related]
7. Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.
Hamill V; Wong S; Benselin J; Krajden M; Hayes PC; Mutimer D; Yu A; Dillon JF; Gelson W; Velásquez García HA; Yeung A; Johnson P; Barclay ST; Alvarez M; Toyoda H; Agarwal K; Fraser A; Bartlett S; Aldersley M; Bathgate A; Binka M; Richardson P; Morling JR; Ryder SD; MacDonald D; Hutchinson S; Barnes E; Guha IN; Irving WL; Janjua NZ; Innes H
BMJ; 2023 Aug; 382():e074001. PubMed ID: 37532284
[TBL] [Abstract][Full Text] [Related]
8. Rising Lysophosphatidylcholine Levels Post-Hepatitis C Clearance.
Peschel G; Krautbauer S; Weigand K; Grimm J; Höring M; Liebisch G; Müller M; Buechler C
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256273
[TBL] [Abstract][Full Text] [Related]
9. Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus.
Chekuri S; Nickerson J; Bichoupan K; Sefcik R; Doobay K; Chang S; DelBello D; Harty A; Dieterich DT; Perumalswami PV; Branch AD
PLoS One; 2016; 11(7):e0159413. PubMed ID: 27442255
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with high alanine aminotransferase (ALT) and cirrhosis in people living with HIV on combination antiretroviral treatment (cART) in the Asia-Pacific.
Rupasinghe D; Choi JY; Yunihastuti E; Kiertiburanakul S; Ross J; Ly PS; Chaiwarith R; Do CD; Chan YJ; Kumarasamy N; Avihingsanon A; Kamarulzaman A; Khusuwan S; Zhang F; Lee MP; Van Nguyen K; Merati TP; Sangle S; Oon Tek N; Tanuma J; Ditangco R; Sim BLH; Pujari S; Jiamsakul A;
J Med Virol; 2022 Nov; 94(11):5451-5464. PubMed ID: 35869413
[TBL] [Abstract][Full Text] [Related]
11. Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995-2016.
Bressler SS; Bruden D; Nolen LD; Bruce MG; Towshend-Bulson L; Spradling P; McMahon BJ
Can J Gastroenterol Hepatol; 2022; 2022():2573545. PubMed ID: 35178364
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs.
Jang TY; Liang PC; Jun DW; Jung JH; Toyoda H; Wang CW; Yuen MF; Cheung KS; Yasuda S; Kim SE; Yoon EL; An J; Enomoto M; Kozuka R; Chuma M; Nozaki A; Ishikawa T; Watanabe T; Atsukawa M; Arai T; Hayama K; Ishigami M; Cho YK; Ogawa E; Kim HS; Shim JJ; Uojima H; Jeong SW; Ahn SB; Takaguchi K; Senoh T; Buti M; Vargas-Accarino E; Abe H; Takahashi H; Inoue K; Huang JF; Chuang WL; Yeh ML; Dai CY; Huang CF; Nguyen MH; Yu ML
Kaohsiung J Med Sci; 2024 Feb; 40(2):188-197. PubMed ID: 37885338
[TBL] [Abstract][Full Text] [Related]
13. Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy.
Nguyen DL; Hu KQ
N Am J Med Sci (Boston); 2014; 7(1):21-27. PubMed ID: 25580186
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication.
Biagi F; Carlomagno F; Carbone M; Veralli R; Vespasiani-Gentilucci U; Riva E; Manfrini S; Tuccinardi D; De Santis A; Gnessi L; Watanabe M
Metabolites; 2023 Oct; 13(11):. PubMed ID: 37999215
[TBL] [Abstract][Full Text] [Related]
15. Late presentation for hepatitis C treatment: prevalence and risk factors in the Swiss Hepatitis C Cohort.
Brunner N; Grischott T; Bruggmann P;
Eur J Gastroenterol Hepatol; 2024 Mar; 36(3):326-331. PubMed ID: 38251444
[TBL] [Abstract][Full Text] [Related]
16. Survival effects of physical activity on mortality among persons with liver disease.
Loprinzi PD; VanWagner LB
Prev Med Rep; 2016 Jun; 3():132-4. PubMed ID: 26844199
[TBL] [Abstract][Full Text] [Related]
17. Elevated liver enzymes in a German tertiary-care hospital: Distribution, diagnostic steps and diagnosis groups.
Bock K; Wedemeyer H; Mederacke YS; Mederacke I
Z Gastroenterol; 2024 Jan; ():. PubMed ID: 38198801
[TBL] [Abstract][Full Text] [Related]
18. Retracted: LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9764203. PubMed ID: 38094457
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of fatty liver and its association with metabolic syndrome among rural adults with chronic hepatitis C: Implications for primary healthcare.
Wang TJ; Chen MY; Lin YC; Chiu WN; Huang TJ; Weng HH
BMC Public Health; 2024 Feb; 24(1):532. PubMed ID: 38378519
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life.
Pugliese N; Polverini D; Arcari I; De Nicola S; Colapietro F; Masetti C; Ormas M; Ceriani R; Lleo A; Aghemo A
Trop Med Infect Dis; 2023 Nov; 8(11):. PubMed ID: 37999621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
